Selected article for: "aPTT partial thromboplastin time and thromboplastin time"

Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
  • ID: 3pnuj5ru_626
    Snippet: Dogs with CKD may have platelet dysfunction, but are hypercoagulable based on elevated TEG values. Platelet receptor expression may not explain changes in platelet function and coagulation Eighteen healthy beagle dogs were used. In group 1 (n = 6), NM was administered at the dose of 0.5 mg/kg/h during 5 hours of IHD. In group 2 (n = 6), NM was administered at the lower dose of 0.25 mg/kg/h during IHD. In group 3 (n = 6), which is the control grou.....
    Document: Dogs with CKD may have platelet dysfunction, but are hypercoagulable based on elevated TEG values. Platelet receptor expression may not explain changes in platelet function and coagulation Eighteen healthy beagle dogs were used. In group 1 (n = 6), NM was administered at the dose of 0.5 mg/kg/h during 5 hours of IHD. In group 2 (n = 6), NM was administered at the lower dose of 0.25 mg/kg/h during IHD. In group 3 (n = 6), which is the control group, unfractionated heparin was administered during IHD. Evaluation parameters included residual blood clot in blood chamber and dialyzer arterial sides, hemoglobin, hemato-crit, platelets, prothrombin time (PT), activated partial thromboplastin time (aPTT) and activated clotting time (ACT).

    Search related documents:
    Co phrase search for related documents
    • ACT clotting time and blood clot: 1
    • ACT clotting time and clotting time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • aPTT partial thromboplastin time and clotting time: 1, 2, 3, 4, 5, 6, 7
    • aPTT partial thromboplastin time and coagulation platelet function: 1
    • aPTT partial thromboplastin time and control group: 1, 2, 3, 4, 5
    • beagle dog and healthy beagle dog: 1
    • blood clot and clotting time: 1, 2, 3, 4
    • blood clot and control group: 1, 2, 3, 4
    • CKD dog and control group: 1, 2
    • clotting time and coagulation platelet function: 1, 2
    • clotting time and control group: 1, 2, 3, 4, 5
    • coagulation platelet function and control group: 1